Skip to main content
Signal8

Cannabis Bioscience International Holdings, Inc. (CBIH)

China Infrastructure Construction Corp. delivers specialized education focusing on medical cannabis to audiences in the United States and Latin America, while also reaching a global market through its online programs. The company further extends its services to therapeutic areas, including supporting clinical trials and offering focused treatment for sleep disorders, specifically those linked to infertility, all managed through its fertility and sleep center located in Houston, Texas. Its Pharmacology University division broadens this scope by providing consulting, digital publishing, marketing, and franchising opportunities, alongside additional educational content related to medical cannabis. Founded in 2003, the organization's main operational hub is situated in Houston, Texas.

Sector: Services-Commercial Physical & Biological Research

Industry: Drug Manufacturers - Specialty & Generic

Cannabis Bioscience International Holdings, Inc. logo

Cannabis Bioscience International Holdings, Inc.

OTC:CBIHHealthcare
$0.0001
Mkt Cap$1.57M
Float3.73B
O/S11.63B
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$303K
Net Income-$549K
Total Assets$32K
Free Cash Flow-$330K
Debt & Equity
Total Debt$420K
Total Equity-$1.16M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in CBIH's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$32K
Liabilities$1.2M
Accounts Receivable$16K
Accounts Payable$100K
Inventory$0
PP&E (Net)$3K
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2010FY 2009FY 2008FY 2007FY 2006
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-05-312024-05-312023-05-312022-05-312021-05-312020-05-312019-05-312018-05-312011-05-312010-05-312009-05-312008-05-312007-05-31
Revenue$303K$249K$317K$215K$762K$580K$98K$40K$83.46M$74M$66.78M$39.3M$18K
YoY Growth21.8%-21.5%47.4%-71.8%31.3%492.9%147.7%-100.0%12.8%10.8%69.9%219332.4%-
Cost of Revenue$40K$46K$93K$47K$4K$0$0$0$56.69M$56.12M$53.78M$33.17M$9K
Gross Profit$263K$203K$223K$168K$758K$580K$98K$40K$26.77M$17.87M$13M$6.13M$9K
Gross Margin86.8%81.7%70.5%78.2%99.5%100.0%100.0%100.0%32.1%24.2%19.5%15.6%49.5%
Research and Development$0$0$0$0$0$0$0$0$14K$0$0$0$0
Selling, General, and Administrative$419K$649K$1.21M$1.06M$873K$809K$101K$1.32M$12.45M$3.74M$1.49M$870K$28K
Other$265K$40K$0$0$0$0$0$0$0$0$0$0$0
Total Operating Expenses$684K$689K$1.21M$1.06M$873K$809K$101K$1.32M$12.46M$3.74M$1.93M$870K$28K
Operating Income (EBIT)-$421K-$486K-$983K-$888K-$115K-$229K-$3K-$1.28M$14.31M$14.14M$11.07M$5.26M-$19K
Operating Margin-139.1%-195.4%-310.4%-413.1%-15.1%-39.4%-2.8%-3245.2%17.1%19.1%16.6%13.4%-105.5%
Interest Expense$180K$165K$91K$51K$44K$8K$0$2K$365K$164K$2K$40K$2K
Interest Income$0$0$0$0$0$0$0$0$2K$4K$0$0$0
Other Income (Expense)-$127K-$165K-$86K$3K-$44K$2K$0-$2K-$102K-$26.72M-$2K-$179K-$2K
Income Before Tax (EBT)-$549K-$651K-$1.07M-$885K-$159K-$226K-$3K-$1.28M$14.21M-$12.59M$11.07M$5.08M-$21K
Income Tax Expense$0$0-$36K$0$0$0$0$0$3.04M$0$0$0$0
Net Income-$549K-$651K-$1.03M-$885K-$159K-$226K-$3K-$1.28M$10.46M-$13.43M$10.46M$4.8M-$21K
Net Income Margin-181.1%-261.8%-325.9%-411.7%-20.9%-39.0%-2.8%-3250.0%12.5%-18.2%15.7%12.2%-117.3%
Supplementary Data
EPS-0.05-0.06-0.10-0.11-0.02-0.03-0.00-0.28808.71-1657.177403.3014552.54-85.79
Diluted EPS-0.05-0.06-0.10-0.11-0.02-0.03-0.00-0.28808.71-1657.177403.3014552.54-85.79
Weighted Average OS10.72M10.32M10.02M8.09M8.25M7.58M4.67M4.51M12,9308,1071,413330245
EBITDA-$336K-$497K-$905K-$834K-$111K-$219K-$3K-$1.28M$16.21M-$11.25M$11.77M$5.73M-$19K
EBITDA Margin-110.7%-199.8%-285.7%-388.0%-14.6%-37.7%-2.8%-3240.3%19.4%-15.2%17.6%14.6%-105.5%
Balance Sheet
PeriodFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2010FY 2009FY 2008FY 2007FY 2006
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-05-312024-05-312023-05-312022-05-312021-05-312020-05-312011-05-312010-05-312009-05-312008-05-312007-05-31
Assets
Current Assets
Cash and Cash Equivalents$13K$755$9K$32K$41K$128K$148K$1.1M$922K$41K$20K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$13K$755$9K$32K$41K$128K$148K$1.1M$922K$41K$20K
Accounts Receivable$16K$20K$11K$18K$13K$0$31.04M$54.36M$26.44M$0$0
Inventory$0$0$0$0$0$0$348K$575K$886K$0$8K
Other Current Assets$598$598$598$0$0$0$0$146K$0$0$0
Total Current Assets$29K$21K$19K$50K$55K$128K$31.54M$56.19M$28.25M$41K$29K
Long-Term Assets
Property, Plant & Equipment Net$3K$36K$24K$60K$94K$0$8.9M$8M$5.65M$0$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$35.33M$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$2.04M$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$0$15.24M$7.53M$945K$0$0
Total Long-Term Assets$3K$36K$24K$60K$94K$0$59.47M$15.53M$6.59M$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0
Total Assets$32K$57K$43K$110K$149K$128K$91M$71.71M$34.84M$41K$29K
Liabilities
Current Liabilities
Accounts Payable$100K$196K$111K$68K$16K$513$13.11M$13.38M$10.17M$33K$33K
Short-Term Debt$166K$161K$136K$139K$160K$197K$0$1.32M$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$6.4M$0$0$0$0
Current Unearned Revenue$0$0$29K$0$0$0$6.4M$0$0$0$0
Other Current Liabilities$51K$503K$105K$16K$11K$3K$3.79M$0$0$0$14K
Total Current Liabilities$946K$882K$386K$223K$187K$201K$27.46M$19.4M$12.75M$33K$52K
Long-Term Liabilities
Long-Term Debt$250K$249K$250K$244K$222K$0$0$0$0$0$14K
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$4K$37K$0$0$0$0$0-$14K
Total Long-Term Liabilities$250K$254K$250K$248K$262K$0-$1.52M$2.19M$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$1.2M$1.14M$635K$471K$450K$201K$25.94M$21.59M$12.75M$33K$52K
Stockholders' Equity
Preferred Stock$0$0$0$3K$3K$500$0$0$0$0$0
Common Stock$0$0$0$0$0$0$43.28M$0$0$0$0
Retained Earnings-$5.88M-$5.33M-$4.68M-$3.65M-$2.76M-$2.18M$14.78M$4.32M$17.76M-$80K-$24K
Comprehensive Income & Other$0$0$0$0$0$0$4.11M$1.51M$1.73M$0$0
Other Stockholders' Equity$4.72M$4.26M$4.09M$3.29M$2.46M$2.11M$4.11M$43.76M$3.13M$87K$400
Total Equity-$1.16M-$1.08M-$592K-$361K-$301K-$73K$62.16M$48.08M$20.88M$7K-$23K
Minority Interest$0$0$0$0$0$0$2.9M$2.05M$1.21M$0$0
Total Liabilities and Equity$32K$57K$43K$110K$149K$128K$88.1M$69.67M$33.63M$41K$29K
Supplementary Data
Total Debt$420K$437K$390K$387K$423K$197K$3.98M$5.45M$0$0$14K
Net Debt$407K$436K$381K$355K$381K$69K$3.84M$4.35M-$922K-$41K-$6K
Cash Flow Statement
PeriodFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2017FY 2010FY 2009FY 2008FY 2007FY 2006
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-05-312024-05-312023-05-312022-05-312021-05-312020-05-312018-05-312011-05-312010-05-312009-05-312008-05-312007-05-31
Operating Activities
Net Income-$549K-$651K-$1.03M-$885K-$159K-$226K-$1.28M$10.46M-$13.43M$11.07M-$56K-$21K
Depreciation & Amortization$33K-$12K$36K$0$4K$0$0$1.64M$1.17M$695K$610K$0
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$0$0$12K$0$0$0$0$0$0$0$19K$0
Changes in Working Capital:
  Accounts Receivable$5K-$10K-$5K-$4K-$6K$3K$0-$13.7M-$28.93M-$15.9M$0$0
  Inventory$0$0$0$0$0$0$0$250K$311K$449K$0$0
  Accounts Payable-$66K$85K$43K$52K-$77K$513$0-$741K$3.2M$4.54M$0$0
  Other Working Capital-$2K-$26K$126K-$32K-$268K$0$1.03M-$7.69M-$589K$1.42M-$112-$30K
Total Working Capital Change-$63K$48K$164K$16K-$352K$3K$1.03M-$21.88M-$26M-$9.49M-$112-$30K
Other Non-Cash Items$249K$135K-$83K-$34K$91K-$3K$250K$27.6M$55.82M$7K-$602K$9K
Net Cash from Operating-$330K-$479K-$913K-$856K-$508K-$223K-$7K$349K-$10.21M$2.28M-$29K-$42K
Investing Activities
Capital Expenditures$0$0$0$0$0$0$0-$924K-$2.69M-$1.87M$0$0
Acquisitions$0$0$0$0$0$0$0$38K$0-$502K$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$0$0$0$1.29M-$1.32M-$2K$0$0
Net Cash from Investing$0$0$0$0$0$0$0$401K-$4.02M-$2.38M$0$0
Financing Activities
Debt Repaid-$122K-$398K-$15K-$33K-$161K-$141K------
Common Stock Issuance$244K$70K$802K$813K$261K$177K$0$0$13.23M$0$50K$0
Common Stock Repurchases$0$0$0$0-$1K-$600$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$0$0$0$0$0$14K$135K-$146K$0$0$0
Net Cash from Financing$342K$471K$890K$846K$421K$317K$14K-$1.74M$14.41M$124K$50K$0
Forex Effect$0$0$0$0$0$0$0$0$0$58K$0$0
Net Change in Cash$12K-$8K-$23K-$9K-$86K$96K-$141K-$1.1M$184K$85K$20K-$42K
Supplementary Data
Operating Cash Flow-$330K-$479K-$913K-$856K-$508K-$223K-$7K$349K-$10.21M$2.28M-$29K-$42K
Capital Expenditure-$4$0$0$0$0$0$0-$924K-$2.69M-$1.87M$0$0
Free Cash Flow-$330K-$479K-$913K-$856K-$508K-$223K-$7K-$575K-$12.9M$405K-$29K-$42K
Cash at Beginning$755$9K$32K$41K$128K$32K$148K$1.25M$1.07M$837K$20K$62K
Cash at End$13K$755$9K$32K$41K$128K$7K$148K$1.25M$922K$41K$20K